Works by Oh, Jaeseong
Results: 65
Cyclic sieving and orbit harmonics.
- Published in:
- Mathematische Zeitschrift, 2022, v. 300, n. 1, p. 639, doi. 10.1007/s00209-021-02800-z
- By:
- Publication type:
- Article
Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen.
- Published in:
- American Journal of Case Reports, 2024, v. 25, p. 1, doi. 10.12659/AJCR.942242
- By:
- Publication type:
- Article
Characteristics of sauna deaths in Korea in relation to different blood alcohol concentrations.
- Published in:
- Forensic Science, Medicine & Pathology, 2018, v. 14, n. 3, p. 307, doi. 10.1007/s12024-018-9993-7
- By:
- Publication type:
- Article
Effect of haemodialysis on the pharmacokinetics and pharmacodynamics of evogliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1769, doi. 10.1111/dom.15034
- By:
- Publication type:
- Article
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin ( DA-1229).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 294, doi. 10.1111/dom.12813
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 1, p. 64, doi. 10.1002/jcph.973
- By:
- Publication type:
- Article
Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13744
- By:
- Publication type:
- Article
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2177, doi. 10.1111/cts.13617
- By:
- Publication type:
- Article
Continuous versus intermittent infusion of human antithrombin III concentrate in the immediate postoperative period after liver transplantation.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 7, p. 1177, doi. 10.1111/cts.13521
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 7, p. 1163, doi. 10.1111/cts.13518
- By:
- Publication type:
- Article
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 3, p. 512, doi. 10.1111/cts.13466
- By:
- Publication type:
- Article
Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 1, p. 92, doi. 10.1111/cts.13429
- By:
- Publication type:
- Article
Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 12, p. 2938, doi. 10.1111/cts.13412
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2744, doi. 10.1111/cts.13401
- By:
- Publication type:
- Article
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2116, doi. 10.1111/cts.13344
- By:
- Publication type:
- Article
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 5, p. 1104, doi. 10.1111/cts.13203
- By:
- Publication type:
- Article
Single‐dose of LC51‐0255, a selective S1P<sub>1</sub> receptor modulator, showed dose‐dependent and reversible reduction of absolute lymphocyte count in humans.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 4, p. 1074, doi. 10.1111/cts.13227
- By:
- Publication type:
- Article
A combinatorial model for the transition matrix between the Specht and SL<sub>2</sub>-web bases.
- Published in:
- Forum of Mathematics, Sigma, 2023, v. 11, p. 1, doi. 10.1017/fms.2023.79
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11038-6
- By:
- Publication type:
- Article
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects.
- Published in:
- Drug Design, Development & Therapy, 2024, v. 18, p. 2641, doi. 10.2147/DDDT.S465652
- By:
- Publication type:
- Article
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects.
- Published in:
- Drug Design, Development & Therapy, 2024, v. 18, p. 395, doi. 10.2147/DDDT.S435885
- By:
- Publication type:
- Article
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects.
- Published in:
- Drug Design, Development & Therapy, 2023, v. 17, p. 2137, doi. 10.2147/DDDT.S409368
- By:
- Publication type:
- Article
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP<sup>®</sup>) Biosimilar, to Those of NESP<sup>®</sup> After a Single Subcutaneous or Intravenous Administration to Healthy Subjects.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 1735, doi. 10.2147/DDDT.S303772
- By:
- Publication type:
- Article
Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 1413, doi. 10.2147/DDDT.S146958
- By:
- Publication type:
- Article
Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 705, doi. 10.2147/DDDT.S124307
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 2525, doi. 10.2147/DDDT.S110712
- By:
- Publication type:
- Article
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 729, doi. 10.2147/DDDT.S75980
- By:
- Publication type:
- Article
Author Correction: A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00935-8
- By:
- Publication type:
- Article
Semimechanistic pharmacokinetic–pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1319, doi. 10.1002/psp4.13012
- By:
- Publication type:
- Article
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize Dosage Regimen.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 10, p. 584, doi. 10.1002/psp4.12555
- By:
- Publication type:
- Article
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176320
- By:
- Publication type:
- Article
Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials.
- Published in:
- Translational & Clinical Pharmacology, 2024, v. 32, n. 1, p. 30, doi. 10.12793/tcp.2024.32.e1
- By:
- Publication type:
- Article
Adaptive design clinical trials: current status by disease and trial phase in various perspectives.
- Published in:
- Translational & Clinical Pharmacology, 2023, v. 31, n. 4, p. 202, doi. 10.12793/tcp.2023.31.e21
- By:
- Publication type:
- Article
Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report.
- Published in:
- Translational & Clinical Pharmacology, 2022, v. 30, n. 2, p. 83, doi. 10.12793/tcp.2022.30.e11
- By:
- Publication type:
- Article
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 3, p. 135, doi. 10.12793/tcp.2021.29.e14
- By:
- Publication type:
- Article
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 1, p. 53, doi. 10.12793/tcp.2021.29.e5
- By:
- Publication type:
- Article
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy.
- Published in:
- Translational & Clinical Pharmacology, 2021, v. 29, n. 1, p. 6, doi. 10.12793/tcp.2021.29.e1
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers.
- Published in:
- Translational & Clinical Pharmacology, 2020, v. 28, n. 4, p. 181, doi. 10.12793/tcp.2020.28.e17
- By:
- Publication type:
- Article
Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.
- Published in:
- Translational & Clinical Pharmacology, 2018, v. 26, n. 2, p. 79, doi. 10.12793/tcp.2018.26.2.79
- By:
- Publication type:
- Article
A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies.
- Published in:
- Translational & Clinical Pharmacology, 2018, v. 26, n. 1, p. 6, doi. 10.12793/tcp.2018.26.1.6
- By:
- Publication type:
- Article
Evaluation of factors associated with drug-induced liver injury using electronic medical records.
- Published in:
- Translational & Clinical Pharmacology, 2016, v. 24, n. 2, p. 78, doi. 10.12793/tcp.2016.24.2.78
- By:
- Publication type:
- Article
Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1127932
- By:
- Publication type:
- Article
Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.930615
- By:
- Publication type:
- Article
Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.842836
- By:
- Publication type:
- Article
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 549, doi. 10.3390/pharmaceutics15020549
- By:
- Publication type:
- Article
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 522, doi. 10.3390/ph17040522
- By:
- Publication type:
- Article
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 132, doi. 10.3390/ph16010132
- By:
- Publication type:
- Article
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 80, doi. 10.1007/s10637-023-01405-z
- By:
- Publication type:
- Article
Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4100, doi. 10.1111/bcp.15348
- By:
- Publication type:
- Article